期刊文献+

人血小板衍生生长因子BB的原核高表达及其包涵体复性 被引量:2

High-Level Expression of Recombinant Human PGDF-BB in Escherichia coli and its Renaturation
下载PDF
导出
摘要 目的:在原核系统内获得高表达的人血小板衍生生长因子BB(PGDF-BB),并对形成的包涵体进行复性。方法:对PGDF-BB核酸编码序列进行优化,构建pET-22b-PGDF-BB表达载体,以提高PCDF-BB的表达量;优化PGDF-BB包涵体复性条件,提高蛋白复性率和生物活性。结果:构建了pET-22b-PGDF-BB高效表达载体,原核表达的重组人PGDF-BB占细菌总蛋白的25%,PGDF-BB包涵体复性率达到15%。结论:对表达序列的优化设计可显著提高蛋白的表达量,复性方法的改良提高了蛋白的复性率和生物活性。 Objective: To improve the expression level of human platelet-derived growth factor BB(PGDF-BB) in E.coli and increase the renaturation ratio of inclusion body. Methods: The sequence of PGDF-BB designed by ancillary software BioSun was synthesized and inserted into plasmid pET-22b to construct pET-PGDF-BB. The pET- PGDF-BB was transformed into E.coli, and PGDF-BB was expressed by induction of IPTG. Then the condition and procedure of renaturation were optimized to improve renaturation ratio and biological activity. Results: After codon optimization, the expression of PGDF-BB was up to 25 % of total bacterial protein. The renaturation ratio of recombinant PGDF-BB was over 15%. Conclusion: The optimization methods applied in this study contributed to improve PGDF-BB expression level and its renaturation ratio.
机构地区 解放军第
出处 《生物技术通讯》 CAS 2015年第1期91-94,共4页 Letters in Biotechnology
基金 国家传染病防治重大项目(2013ZX-10003-006)
关键词 人血小板衍生生长因子BB 高表达 包涵体 复性 human platelet-derived growth factor high-level expression inclusion body renaturation
  • 相关文献

参考文献5

  • 1Andrae J,Gallini R,Betsholtz C.Role of platelet-derivedgrowth factors in physiology and medicine[J].Genes Dev,2008,22(10):1276-1312.
  • 2Okano J,Nagahara T,Malsumoto K,et al.Caffeine inhibitsthe proliferation of liver cancer cells and activates the MEK/ERK/EGFR signaling pathway[J].Basic Clin Pharmacol Toxi-col,2008,102(6):543-551.
  • 3Inoue K,Cynshi O,Kawabe Y,et al.Effect of BO-653 andprobucol on c-MYC anti PDGF-A messenger RNA of the ili-ac artery after balloon denudation in cholesterol-fed rabbitsIJ I.Atherosclerosis,2002,161(2):353-363.
  • 4Branski L K,Pereira C T,Herndon D N,et al.Gene thera-py in wound healing:present status and future directions[J].Gene Ther,2007,14(1):1-10.
  • 5Cook A,Kirwin P,Craig S,et al.Purification and analysis ofproteinase resistant mutants of recombinant platelet-derivedgrowth factor-BB exhibiting improved biological activity[J].Bio-chem J,1992,281(Ptl):57-65.

同被引文献20

  • 1金小宝,王艳,朱家勇.诱导前后美洲大蠊血淋巴抗菌活性的研究[J].广东药学院学报,2006,22(6):665-666. 被引量:9
  • 2王荫长.昆虫生物化学[M].北京:中国农业出版社,2004.245-270.
  • 3萨姆布鲁克J,拉塞尔Dw.分子克隆实验指南[M].第3版.北京:科学出版社,2008:32-36.
  • 4Li L, Zhao J, Wang L, et al. Genomic organization, polymorphisms and molecular evolution of the goose-type lysozyme gene from Zhikong Scallop Chlamysfarreri[J]. Gene, 2013, 513(1):40-52.
  • 5Mitra P, Banerjee M, Biswas S, et al. Protein interactions of Merocyanine 540:spectroscopic and crystallographic studies with lysozyme as a model protein[J]. J Photochem Photobiol, B:Biology, 2013, 121:46-56.
  • 6Huang P, Li WS, Xie J, et al. Charaterization and expression of HLysG2, a basic goose-type lysozyme from the human eye and testis[J]. Mol Immunol, 2011, 48(4):524-531.
  • 7Callewaert L, Michiels CW. Lysozyme in the animal kingdom[J]. J Biosci, 2010, 35(1):127-160.
  • 8Lapcharoen P, Komalamisra N, Rongsriyam Y, et al. Investigations on the role of a lysozyme from the malaria vector Anopheles dirus during malaria parasite development[J]. Dev Comp Immunol, 2012, 36(1):104-111.
  • 9Karthik V, Kamalakannan V, Thomas A, et al. Functional characterization of a c-type lysozyme from Indian shrimp Fenneropenaeus indicus[J]. Probiotics Antimicrob Proteins, 2014, 6(2):114-121.
  • 10Yue X, Liu B, Xue Q. An i-type lysozyme from the Asiatic hard clam Meretrix meretrix potentially functioning in host immunity[J]. Fish Shellfish Immunol, 2011, 30(2):550-558.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部